Find a Cancer Program  Log in to MyNetwork

Home > Resources > Molecular Testing: Overview

Molecular Testing in the Community Oncology Setting

Molecular Testing in the Community Oncology Setting

The evolution of personalized medicine is having an impact on oncology patient care—both diagnostically and therapeutically. The growth in both volume and complexity of molecular tests is presenting challenges for oncology and pathology programs.

While these tests have been accepted into general practice guidelines once clinical utility is proven, adoption and use of molecular tests in the community setting have been slower and somewhat fragmented. Understanding the challenges around molecular testing for community-based providers is important to both practicing clinicians and the patients they serve.

ACCC's project on Molecular Testing in the Community Oncology Setting consists of two phases:


 

Phase 1: Understanding the Landscape and Identifying Best Practices

The Phase 1 project provided an environmental scan of molecular testing in the community setting and an understanding of issues surrounding adoption and implementation of molecular testing in the community-based care settings.

A literature search revealed that to date little has been published on the non-clinical aspects of the use of molecular testing in the community setting. Two surveys conducted for the Phase 1 project indicated that molecular testing is a technical and clinical aspect of cancer care that is often not well understood by all members of the cancer care team. Follow-up research identified additional barriers, strategies for overcoming barriers to integration of molecular testing, and effective practices for molecular testing in the community setting.


Phase 2: Learning Labs for Process Improvement

Molecular Testing in the Community Oncology Setting: Learning Labs for Process Improvement activates Phase 2 of ACCC’s molecular testing education project. Information gleaned during the Phase 1 project revealed a need for process improvement support for implementation of molecular testing in the community setting with a focus on multidisciplinary communication and collaboration.

To help meet this need, the Phase 2 initiative will provide eight on–site experiential multidisciplinary learning labs with a focus on molecular testing in lung cancer. The following ACCC–member programs were selected, through an application process, to participate as learning lab sites:

Anne Arundel Medical Center, DeCesaris Cancer Institute
Annapolis, MD

IU Health Goshen Center for Cancer Care
Goshen, IN

Riverside Health System, Riverside Cancer Care Center
Newport News, VA

Shawnee Mission Medical Center
Shawnee Mission, KS

Southside Regional Medical Center
Petersburg, VA

St. Vincent's HealthCare
Jacksonville, FL

The Methodist Hospitals, Oncology Services
Merrillville, IN

The Thomas Johns Cancer Hospital
Richmond, VA

The learning labs will provide an effective, practical educational intervention focused on quality improvement, and will include:

Following the learning lab, each center will report on progress in implementing its process improvement plan.

Results and lessons learned from the participating sites will be shared in a final report, on the project website, and at the ACCC 2014 National Oncology Conference.

If you have any comments about this project, we would like to hear from you.

 

ACCC Footer Links

Copyright © 2014 Association of Community Cancer Centers. All Rights Reserved.
11600 Nebel Street, Suite 201, Rockville, MD 20852  |  Tel.: 301.984.9496  |  Fax: 301.770.1949

CONTACT US